18103-Prostate Cancer-NA-1517

Prostate Cancer

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer(64091742PCR3001)

  • Details

ClinicalTrials.gov ID: NCT03748641
Diagnosis Type: NA
USOR Number: 18103

  • Address

5236 W University Dr, Suite 1000
McKinney, TX 75071
P: (972) 542-8609

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.